Papillary thyroid cancer—Aggressive variants and impact on management: A narrative review
A Coca-Pelaz, JP Shah, JC Hernandez-Prera… - Advances in …, 2020 - Springer
Introduction Aggressive variants of papillary thyroid cancer (PTC) have been described with
increasing frequency. These variants include diffuse sclerosing variant, tall cell variant …
increasing frequency. These variants include diffuse sclerosing variant, tall cell variant …
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
G Acquaviva, M Visani, A Repaci, KJ Rhoden… - …, 2018 - Wiley Online Library
Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …
Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
C Koelsche, A Wöhrer, A Jeibmann, J Schittenhelm… - Acta …, 2013 - Springer
Ganglioglioma is a rare CNS tumor with a benign biological behavior. Recently, the BRAF
V600E mutation was identified in approximately 20% of gangliogliomas. Here, we analyzed …
V600E mutation was identified in approximately 20% of gangliogliomas. Here, we analyzed …
BRAF V600E mutation-specific antibody: a review
LL Ritterhouse, JA Barletta - Seminars in diagnostic pathology, 2015 - Elsevier
The significance of BRAF mutations in neoplasia was first recognized in 2002 when
mutations were discovered in a broad range of cancers. Numerous subsequent studies …
mutations were discovered in a broad range of cancers. Numerous subsequent studies …
Clinicopathological relevance of BRAF mutations in human cancer
S Pakneshan, A Salajegheh, RA Smith… - Pathology-Journal of …, 2013 - journals.lww.com
BRAF represents one of the most frequently mutated protein kinase genes in human
tumours. The mutation is commonly tested in pathology practice. BRAF mutation is seen in …
tumours. The mutation is commonly tested in pathology practice. BRAF mutation is seen in …
Application of immunohistochemistry in thyroid pathology
H Liu, F Lin - Archives of Pathology and Laboratory …, 2015 - meridian.allenpress.com
Context Accurate classification of follicular-patterned thyroid lesions is not always an easy
task on routine surgical hematoxylin-eosin–stained or cytologic fine-needle aspiration …
task on routine surgical hematoxylin-eosin–stained or cytologic fine-needle aspiration …
[HTML][HTML] Detection of BRAF p. V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing
E Colomba, Z Hélias-Rodzewicz… - The Journal of molecular …, 2013 - Elsevier
BRAF p. V600 mutation detection recently became necessary to treat metastatic melanoma
patients with vemurafenib. This study compares different methods of detection of BRAF …
patients with vemurafenib. This study compares different methods of detection of BRAF …
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome
BRAFV600E mutation in microsatellite-unstable (MSI) colorectal carcinomas (CRCs)
virtually excludes Lynch syndrome (LS). In microsatellite-stable (MSS) CRCs it predicts poor …
virtually excludes Lynch syndrome (LS). In microsatellite-stable (MSS) CRCs it predicts poor …
Diffuse sclerosing variant of papillary thyroid carcinoma—an update of its clinicopathological features and molecular biology
Diffuse sclerosing variant of papillary thyroid carcinoma (DSVPTC) is an uncommon variant
of papillary thyroid carcinoma. The aim of this review is to critically analyse the features of …
of papillary thyroid carcinoma. The aim of this review is to critically analyse the features of …
BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer
D Capper, A Voigt, G Bozukova… - … journal of cancer, 2013 - Wiley Online Library
The differentiation between hereditary and sporadic microsatellite‐unstable (MSI‐H)
colorectal cancer is a crucial step in Lynch syndrome diagnostics. Within MSI‐H colorectal …
colorectal cancer is a crucial step in Lynch syndrome diagnostics. Within MSI‐H colorectal …